Medical device and MedTech insights, news, tips and more

Google AI Tool Bests Clinicians in Breast Cancer Detection Study 

January 3, 2020

Breast Cancer Identification Imaging

Breast Cancer Identification Imaging

A Google artificial intelligence tool may predict breast cancer better than doctors, according to a study published Wednesday in the journal Nature.

The algorithm, which was trained on almost 91,000 mammogram scans from women in the U.S. and U.K., resulted in almost 6% fewer incorrect cancer diagnoses and 9% fewer false negatives than standard clinical practice when used in the U.S. In the U.K. those figures were 1% and 3% respectively.

Yet the evidence for AI’s value-add in diagnostics is still shaky. Developers of such algorithms stress they should be used as tools on top of a clinician’s judgment, not a stand-alone diagnostic in place of it.

Roughly one in eight women in the U.S. will develop invasive breast cancer over the course of her lifetime, according to the American Cancer Society. Early detection of abnormal tissue or tumor is critically important for treatment, but mammograms have their limitations.​

Clinicians fail to catch about a fifth of all breast cancer cases, and half of U.S. women receiving annual mammograms in a given decade will be incorrectly told they have breast cancer when they actually don’t, the cancer group says.

Google Health’s new tool, developed in tandem with its British subsidiary DeepMind, Northwestern Medicine and Imperial College London and the University of Cambridge, improved mistakes in both areas. False positives were reduced by 5.7% and 1.2%, and false negatives were reduced by 9.4% and 2.7% in the U.S. and U.K., respectively.

See Full Article: Google AI tool bests clinicians in breast cancer detection study | Healthcare Dive

Written by: Rebecca Pifer

Legacy MedSearch has more than 30 years of combined experience recruiting in the medical device industry. We pride ourselves on our professionalism and ability to communicate quickly and honestly with all parties in the hiring process. Our clients include both blue-chip companies and innovative startups within the MedTech space. Over the past 10 years, we have built one of the strongest networks of device professionals ranging from sales, marketing, research & , quality & regulatory, project management, field service, and clinical affairs.

We offer a variety of different solutions for hiring managers depending on the scope and scale of each individual search. We craft a personalized solution for each client and position with a focus on attracting the best possible talent in the shortest possible time frame.

Are you hiring?

Contact us to discuss partnering with Legacy MedSearch on your position.

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.